期刊文献+

S100A9对宫颈癌Hela细胞的增殖和迁移的影响及其机制探讨 被引量:4

The Effects of S100A9 on Proliferation and Migration of Human Squamous Cervical Carcinoma Hela Cell Line and Its Mechanisms
原文传递
导出
摘要 为初步探讨S100A9在宫颈癌中的生物学作用,利用携带有人S100A9基因的腺病毒(Adh S100A9)感染于低表达S100A9的宫颈癌Hela细胞,通过MTT法检测细胞增殖能力,划痕愈合试验和Transwell试验检测细胞迁移能力,通过倒置显微镜观察细胞形态变化,采用RT-PCR和蛋白质印迹法检测上皮细胞标志蛋白E-钙黏着蛋白(E-cadherin,E-cad)、间质细胞标志蛋白波形蛋白(vimentin,Vim)及Wnt/β-联蛋白(β-catenin,β-cat)信号通路相关分子的表达。结果显示,与对照组相比,过表达S100A9的Hela细胞增殖活性增强、迁移率增高,细胞形态由"铺路石"样向"梭形"转变,排列紊乱,伴随E-cad降低(P<0.05)和Vim升高(P<0.01);同时,过表达S100A9的Hela细胞中Wnt/β-cat信号通路的关键分子β-联蛋白水平增加(P<0.01),并且入核增多(P<0.01),该通路的下游靶基因c-myc、Snail及Twist表达也明显上调。该研究结果提示,S100A9促进宫颈癌Hela细胞的增殖、迁移和上皮–间质转化(epithelial-mesenchymal transition,EMT),激活Wnt/β-cat信号通路;S100A9促进增殖和迁移作用的机制可能与其促进EMT和激活Wnt/β-cat信号通路相关。 To investigate the role of S100A9 in human squamous cervical carcinoma, the cervical carci- noma cells (Hela cell line) were infected with recombinant adenovirus expressing S100A9. Then, MTT was used to detect cell proliferation; Wound-healing test and Transwell assay were used to determine cell migration; Inverted microscope was used to observe the morphologic changes; Reverse transcription-PCR (RT-PCR) and Western blot were utilized to detect the mRNA or protein levels of E-Cadherin, Vimentin and the relevant molecules of Wnt/ β-catenin signaling pathway, respectively. The results showed that S100A9 over-expression promoted the prolifera- tion and migration of Hela cells, and induced a morphology transition from a round cobblestone-like phenotype to a slender and fusiform appearance, also led to reduction of E-cadherin (P〈0.05) and increase of Vimentin (P〈0.01). Moreover, the levels of β-catenin, c-myc, Snail and Twist in S 100A9 over-expressed Hela cells were also increased. The results demonstrated that S 100A9 could promote the proliferation, migration and epithelial-mesenchymal tran-sition (EMT) of Hela cells and also activated the WntJl3-catenin signaling pathway. The mechanisms that S 100A9 increased the cell proliferation and migration of Hela cell line might be associated with its promoting effect on EMT and the Wnt/β-catenin signaling pathway.
出处 《中国细胞生物学学报》 CAS CSCD 2015年第12期1632-1638,共7页 Chinese Journal of Cell Biology
关键词 S100A9 宫颈癌 增殖 迁移 上皮间质转化 Wnt/β-联蛋白信号通路 S 100A9 cervical carcinoma cell proliferation cell migration epithelial-mesenchymal transi-tion Wnt/β-catenin signaling pathway
  • 相关文献

参考文献17

  • 1Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61 (2): 69-90.
  • 2Kodama J, Seki N, Masahiro S, Kusumoto T, Nakamura K, Hongo A, et al. Prognostic factors in stage IB-IIB cervical adeno- carcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy. J Surg Onco12010, 101(5): 413-7.
  • 3Schafer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW. Isolation of a YAC clone covering a cluster of nine S 100 genes on human chromosome 1 q21: Rationale for a new nomenclature of the S100 calclum-binding protein family. Genomics 1995, 25(3): 638-43.
  • 4Kawai H, Minamiya Y, Takahashi N. Prognostic impact of S100A9 overexpression in non-small cell lung cancer. Tumour Biol 2011, 32(4): 641-6.
  • 5Fan B, Zhang LH, Jia YN, Zhong XY, Liu YQ, Cheng X J, et al. Presence of S 100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer. BMC Cancer 2012, 12: 316.
  • 6McKiernan E, McDermott EW, Evoy D, Crown J, Duffy MJ. The role of $100 genes in breast cancer progression. Tumour Biol 2011, 32(3): 441-50.
  • 7Arai K, Takano S, Teratani T, Ito Y, Yamada T, Nozawa R. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curt Cancer Drug Targets 2008, 8(4): 243-52.
  • 8Chao A, Wang TH, Lee YS, Hsueh S, Chao AS, Chang TC, et al. Molecular characterization of adenoearcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 2006, 119(1): 91-8.
  • 9Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to over- come drug resistance in the clinic. Biochim Biophys Acta 2009, 1796(2): 75-90.
  • 10Qureshi R, Arora H, Rizvi MA. EMT in cervical cancer: Its role in tumour progression and response to therapy. Cancer Lett 2015, 356(2 Pt B): 321-31.

同被引文献34

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部